Rüdiger Ridder

933 total citations
10 papers, 741 citations indexed

About

Rüdiger Ridder is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rüdiger Ridder has authored 10 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rüdiger Ridder's work include Cervical Cancer and HPV Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Protein purification and stability (3 papers). Rüdiger Ridder is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Protein purification and stability (3 papers). Rüdiger Ridder collaborates with scholars based in Germany, Australia and Switzerland. Rüdiger Ridder's co-authors include Magnus von Knebel Doeberitz, Hermann Gram, C. Simon Herrington, David Jenkins, Robert J. Kurman, Axel Benner, Rüdiger Klaes, Dietmar Schmidt, Mark H. Stoler and Rita Schmitz and has published in prestigious journals such as Nature Biotechnology, British Journal of Cancer and Gene.

In The Last Decade

Rüdiger Ridder

10 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rüdiger Ridder Germany 6 335 230 214 204 115 10 741
Nuria Perez‐Reyes United States 13 301 0.9× 253 1.1× 169 0.8× 161 0.8× 17 0.1× 16 792
Maria Teresa Perra Italy 17 73 0.2× 249 1.1× 82 0.4× 213 1.0× 209 1.8× 52 833
Charlotte A. Brown United States 22 208 0.6× 489 2.1× 128 0.6× 170 0.8× 6 0.1× 44 1.0k
Edward Quinlan United States 12 107 0.3× 331 1.4× 29 0.1× 54 0.3× 511 4.4× 17 1.1k
Caroline Geisen Germany 14 225 0.7× 535 2.3× 106 0.5× 351 1.7× 16 0.1× 24 980
Dan P. Hartmann United States 10 94 0.3× 134 0.6× 46 0.2× 186 0.9× 36 0.3× 12 543
Eugene Daniels Canada 15 92 0.3× 413 1.8× 61 0.3× 141 0.7× 162 1.4× 29 919
Niema Ibrahim Saudi Arabia 17 78 0.2× 411 1.8× 97 0.5× 75 0.4× 13 0.1× 22 767
Kazuhisa Hasui Japan 15 58 0.2× 160 0.7× 74 0.3× 134 0.7× 34 0.3× 60 602
Cristina Maxia Italy 16 64 0.2× 232 1.0× 67 0.3× 208 1.0× 185 1.6× 47 739

Countries citing papers authored by Rüdiger Ridder

Since Specialization
Citations

This map shows the geographic impact of Rüdiger Ridder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüdiger Ridder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüdiger Ridder more than expected).

Fields of papers citing papers by Rüdiger Ridder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rüdiger Ridder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüdiger Ridder. The network helps show where Rüdiger Ridder may publish in the future.

Co-authorship network of co-authors of Rüdiger Ridder

This figure shows the co-authorship network connecting the top 25 collaborators of Rüdiger Ridder. A scholar is included among the top collaborators of Rüdiger Ridder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rüdiger Ridder. Rüdiger Ridder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Nindl, Ingo, Thomas Meyer, Tobias Schmook, et al.. (2004). Human Papillomavirus and Overexpression of P16INK4a in Nonmelanoma Skin Cancer. Dermatologic Surgery. 30(3). 409–414. 28 indexed citations
3.
Nindl, Ingo, Thomas Meyer, Tobias Schmook, et al.. (2004). Human Papillomavirus and Overexpression of P16INK4a in Nonmelanoma Skin Cancer. Dermatologic Surgery. 30(3). 409–414. 3 indexed citations
4.
Herr, Ingrid, Kerstin Herzer, Rüdiger Ridder, et al.. (2003). Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.. PubMed. 63(12). 3112–20. 165 indexed citations
5.
Ridder, Rüdiger, Nicolas Wentzensen, & Magnus von Knebel Doeberitz. (2003). Biomarker in der Differenzialdiagnostik von HPV-assoziierten Läsionen. Der Gynäkologe. 36(4). 323–330. 1 indexed citations
6.
Klaes, Rüdiger, Axel Benner, Rüdiger Ridder, et al.. (2002). p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia. The American Journal of Surgical Pathology. 26(11). 1389–1399. 354 indexed citations
7.
Gram, Hermann, Rita Schmitz, & Rüdiger Ridder. (1998). Secretion of scFv Antibody Fragments. Methods in molecular biology. 103. 179–192. 5 indexed citations
8.
Ridder, Rüdiger, et al.. (1997). Inhibition of cisplatin-induced apoptosis by dexamethasone in cervical and bronchial carcinoma cells. European Journal of Cancer. 33. S173–S173. 1 indexed citations
9.
Ridder, Rüdiger, Sabine Geisse, Beate Kleuser, Petra Kawalleck, & Hermann Gram. (1995). A COS-cell-based system for rapid production and quantification of scFv::IgCκ antibody fragments. Gene. 166(2). 273–276. 14 indexed citations
10.
Ridder, Rüdiger, Rita Schmitz, François Legay, & Hermann Gram. (1995). Generation of Rabbit Monoclonal Antibody Fragments from a Combinatorial Phage Display Library and Their Production in the Yeast Pichia pastoris. Nature Biotechnology. 13(3). 255–260. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026